Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic review

CONCLUSION: KarXT offers an innovative non-D2 blocking approach, representing a promising treatment avenue for schizophrenia.PMID:38515004 | DOI:10.1080/14656566.2024.2334424

Source: Expert Opinion on Pharmacotherapy - March 22, 2024 Category: Drugs & Pharmacology Authors: Alexia Leber Ranuk Ramachandra Felicia Ceban Angela T H Kwan Taeho Greg Rhee Jie Wu Bing Cao Muhammad Youshay Jawad Kayla M Teopiz Roger Ho Gia Han Le Diluk Ramachandra Roger S McIntyre Source Type: research